• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单克隆抗体(MAb 17-1A)治疗的转移性结直肠癌患者的免疫组化监测

Immunohistochemical monitoring of metastatic colorectal carcinoma in patients treated with monoclonal antibodies (MAb 17-1A).

作者信息

Shetye J, Frödin J E, Christensson B, Grant C, Jacobsson B, Sundelius S, Sylvén M, Biberfeld P, Mellstedt H

机构信息

Department of Pathology, Karolinska Institute and Hospital, Stockholm, Sweden.

出版信息

Cancer Immunol Immunother. 1988;27(2):154-62. doi: 10.1007/BF00200021.

DOI:10.1007/BF00200021
PMID:3262013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11038272/
Abstract

A therapeutic trial using repeated doses of a mouse monoclonal antibody against the tumor-associated antigen (TAA) CO17-1A in metastatic colorectal carcinomas was carried out. Metastatic lesions sampled by repeated thick needle (1.2 mm) biopsies during therapy were examined immunohistochemically for the presence of various TAAs, mouse IgG, complement, and infiltrating leukocytes. The CO17-1A was consistently expressed in all cases along the basement membrane of tumor glands and could only be demonstrated on cryostat sections whereas the TAAs GICA19-9, GA73-3, and Br55-2 were also visualized in B5-fixed paraffin-embedded biopsies. The CO17-1A and GA73-3 were predominantly present at the basal region in contrast to the GICA 19-9 and Br55-2 which were predominant at the luminal and the apical region of the tumor glands. Antigenic modulation was not seen either after 24-72 h or during prolonged treatment. In all cases the infused mouse IgG was detected, from 24 h after infusion up to 6-8 weeks, mainly along the basal region of tumor glands. In 13/14 posttreatment biopsies, complement factor C3 was found at the same sites as mouse IgG. In 6 out of 9 posttreatment biopsies an increase in mononuclear cells (monocytes, natural killer (NK) cells and/or T cells) was observed. Monocytes were close to the tumor cells whereas NK cells and T cells were predominantly scattered in the stroma.

摘要

开展了一项治疗试验,使用针对肿瘤相关抗原(TAA)CO17-1A的小鼠单克隆抗体重复给药治疗转移性结直肠癌。在治疗期间,通过重复粗针(1.2毫米)活检获取转移性病变样本,对其进行免疫组织化学检查,以检测各种TAA、小鼠IgG、补体和浸润白细胞的存在情况。CO17-1A在所有病例中均沿肿瘤腺管基底膜持续表达,且仅在低温恒温器切片上可见,而TAA GICA19-9、GA73-3和Br55-2在B5固定的石蜡包埋活检样本中也能显示。与主要位于肿瘤腺管腔面和顶端区域的GICA 19-9和Br55-2不同,CO17-1A和GA73-3主要存在于基底区域。在24至72小时后或长期治疗期间均未观察到抗原调制现象。在所有病例中,从输注后24小时直至6至8周,均可检测到输注的小鼠IgG,主要沿肿瘤腺管基底区域分布。在14份治疗后活检样本中的13份中,在与小鼠IgG相同的部位发现了补体因子C3。在9份治疗后活检样本中的6份中,观察到单核细胞(单核细胞、自然杀伤(NK)细胞和/或T细胞)增多。单核细胞靠近肿瘤细胞,而NK细胞和T细胞主要散布在基质中。

相似文献

1
Immunohistochemical monitoring of metastatic colorectal carcinoma in patients treated with monoclonal antibodies (MAb 17-1A).单克隆抗体(MAb 17-1A)治疗的转移性结直肠癌患者的免疫组化监测
Cancer Immunol Immunother. 1988;27(2):154-62. doi: 10.1007/BF00200021.
2
Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.重组γ干扰素与鼠单克隆抗体CO17-1A用于晚期结直肠癌的II期试验中的抗体递送与效应细胞激活
Cancer Res. 1988 May 1;48(9):2568-73.
3
Isolation and characterization of autologous blood mononuclear cells used for auto-infusion together with monoclonal antibodies in tumor treatment.
Hybridoma. 1987 Dec;6(6):555-64. doi: 10.1089/hyb.1987.6.555.
4
Treatment of patients with metastasizing colo-rectal carcinoma with mouse monoclonal antibodies (Moab 17-1A): a progress report.
Hybridoma. 1986 Jul;5 Suppl 1:S151-61.
5
Patients treated with a monoclonal antibody (ab1) to the colorectal carcinoma antigen 17-1A develop a cellular response (DTH) to the "internal image of the antigen" (ab2).用针对结肠直肠癌抗原17-1A的单克隆抗体(ab1)治疗的患者会对“抗原内影像”(ab2)产生细胞反应(迟发型超敏反应)。
Int J Cancer. 1991 May 30;48(3):344-9. doi: 10.1002/ijc.2910480306.
6
Anti-idiotypic antibodies to monoclonal antibody CO17-1A.抗单克隆抗体CO17-1A的抗独特型抗体。
Hybridoma. 1986 Jul;5 Suppl 1:S51-8.
7
Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A.自然杀伤(NK)细胞功能是接受单克隆抗体17-1A治疗的结直肠癌患者的一个重要预后因素。
Int J Cancer. 2003 Jul 10;105(5):717-23. doi: 10.1002/ijc.11139.
8
Effect of human blood mononuclear cell populations in antibody dependent cellular cytotoxicity (ADCC) using two murine (CO17-1A and Br55-2) and one chimeric (17-1A) monoclonal antibodies against a human colorectal carcinoma cell line (SW948).使用两种抗人结肠癌细胞系(SW948)的鼠源单克隆抗体(CO17 - 1A和Br55 - 2)以及一种嵌合单克隆抗体(17 - 1A),研究人血单核细胞群体在抗体依赖性细胞毒性(ADCC)中的作用。
Hybridoma. 1988 Oct;7(5):429-40. doi: 10.1089/hyb.1988.7.429.
9
Detection of murine immunoglobulin in human tissues following therapeutic infusion of monoclonal antibody.治疗性输注单克隆抗体后人体组织中鼠免疫球蛋白的检测
Hybridoma. 1986 Jul;5 Suppl 1:S79-86.
10
Growth suppression of colorectal cancer by plant-derived multiple mAb CO17-1A × BR55 via inhibition of ERK1/2 phosphorylation.植物源多克隆抗体CO17-1A×BR55通过抑制ERK1/2磷酸化抑制结直肠癌生长
Int J Mol Sci. 2014 Nov 14;15(11):21105-19. doi: 10.3390/ijms151121105.

引用本文的文献

1
Past, present and future targets for immunotherapy in ovarian cancer.卵巢癌免疫治疗的过去、现在和未来目标
Immunotherapy. 2014;6(12):1279-93. doi: 10.2217/imt.14.90.
2
Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer.上皮细胞粘附分子导向的三功能抗体免疫疗法用于晚期卵巢癌症状管理
Clin Pharmacol. 2013 Oct 3;5(Suppl 1):55-61. doi: 10.2147/CPAA.S45885.
3
Hepatocytes isolated from neoplastic liver-immunomagnetic purging as a new source for transplantation.从肿瘤肝脏中分离的肝细胞——免疫磁珠清除法作为移植的新来源。
World J Gastroenterol. 2008 Aug 28;14(32):5025-31. doi: 10.3748/wjg.14.5025.
4
Recombinant chimeric antibody hCAb as a novel anti-human colorectal carcinoma agent.重组嵌合抗体hCAb作为一种新型抗人结肠直肠癌药物。
Mol Med. 2006 Sep-Oct;12(9-10):229-36. doi: 10.2119/2006-00021.Xiong.
5
Serum antibodies to EpCAM in healthy donors but not ulcerative colitis patients.健康供体而非溃疡性结肠炎患者体内存在抗EpCAM血清抗体。
Cancer Immunol Immunother. 2006 May;55(5):528-37. doi: 10.1007/s00262-005-0026-5. Epub 2005 Jul 21.
6
Molecular identification of a human carcinoma-associated glycoprotein antigen recognized by mouse monoclonal antibody FU-MK-1.一种被小鼠单克隆抗体FU-MK-1识别的人类癌相关糖蛋白抗原的分子鉴定
Jpn J Cancer Res. 2000 Feb;91(2):231-8. doi: 10.1111/j.1349-7006.2000.tb00936.x.
7
Edrecolomab (monoclonal antibody 17-1A).依德瑞单抗(单克隆抗体17-1A)。
Drugs. 1998 Oct;56(4):619-26; discussion 627-8. doi: 10.2165/00003495-199856040-00011.
8
The impact of antigen density and antibody affinity on antibody-dependent cellular cytotoxicity: relevance for immunotherapy of carcinomas.抗原密度和抗体亲和力对抗体依赖性细胞毒性的影响:对癌免疫治疗的相关性。
Br J Cancer. 1998 Aug;78(4):478-83. doi: 10.1038/bjc.1998.518.
9
Expression of an antigen homologous to the human CO17-1A/GA733 colon cancer antigen in animal tissues.一种与人类CO17-1A/GA733结肠癌抗原同源的抗原在动物组织中的表达。
Br J Cancer. 1997;76(7):909-16. doi: 10.1038/bjc.1997.483.
10
The therapeutic use of the unconjugated monoclonal antibodies (MAb) 17-1A in combination with GM-CSF in the treatment of colorectal carcinoma (CRC).未结合的单克隆抗体(MAb)17-1A与粒细胞巨噬细胞集落刺激因子(GM-CSF)联合用于治疗结直肠癌(CRC)的治疗用途。
Med Oncol Tumor Pharmacother. 1993;10(1-2):61-70. doi: 10.1007/BF02987770.

本文引用的文献

1
The spread of rectal cancer and its effect on prognosis.直肠癌的扩散及其对预后的影响。
Br J Cancer. 1958 Sep;12(3):309-20. doi: 10.1038/bjc.1958.37.
2
Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum.影响结肠或直肠癌肝转移患者生存的因素。
Dis Colon Rectum. 1982 Nov-Dec;25(8):749-54. doi: 10.1007/BF02553304.
3
A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II.一种与胃肠道癌相关的单克隆抗体定义抗原是一种含有唾液酸化乳糖-N-岩藻五糖II的神经节苷脂。
J Biol Chem. 1982 Dec 10;257(23):14365-9.
4
An immunohistological study of human lymphoma.人类淋巴瘤的免疫组织学研究。
Clin Exp Immunol. 1980 May;40(2):235-48.
5
Prognostic factors influencing survival of patients with advanced colorectal cancer: hepatic-artery infusion versus systemic intravenous chemotherapy for liver metastases.
J Clin Oncol. 1984 Mar;2(3):174-80. doi: 10.1200/JCO.1984.2.3.174.
6
Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis.由IgG2a同种型单克隆抗体诱导发生排斥反应的肿瘤,含有数量增多的巨噬细胞,这些巨噬细胞被激活以进行一种独特形式的抗体依赖性细胞溶解。
Proc Natl Acad Sci U S A. 1984 Jun;81(11):3506-10. doi: 10.1073/pnas.81.11.3506.
7
Efficient selection of human tumor growth-inhibiting monoclonal antibodies.高效筛选人肿瘤生长抑制性单克隆抗体。
J Immunol Methods. 1984 Oct 12;73(1):157-67. doi: 10.1016/0022-1759(84)90041-3.
8
Binding of murine immunoglobulin to human tissues after immunotherapy with anticolorectal carcinoma monoclonal antibody.
Int J Cancer. 1984 Apr 15;33(4):465-8. doi: 10.1002/ijc.2910330408.
9
IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells.IgG2a单克隆抗体通过与效应细胞相互作用抑制人类肿瘤生长。
Proc Natl Acad Sci U S A. 1982 Aug;79(15):4761-5. doi: 10.1073/pnas.79.15.4761.
10
Leu 7+ (HNK-1+) cells. I. Selective compartmentalization of Leu 7+ cells with different immunophenotypes in lymphatic tissues and blood.
Scand J Immunol. 1983 Dec;18(6):485-93. doi: 10.1111/j.1365-3083.1983.tb00882.x.